Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | ACE2 | Q9BYF1 | 3/20 | 0.38 |
| ▸ | THRB | P10828 | 4/20 | 0.35 |
| ▸ | PPARG | P37231 | 3/20 | 0.34 |
| ▸ | CNR1 | P21554 | 3/20 | 0.33 |
| ▸ | CNR2 | P34972 | 3/20 | 0.33 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.33 |
| ▸ | THRA | P10827 | 1/20 | 0.33 |
| ▸ | PTGES | O14684 | 1/20 | 0.32 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.32 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.32 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19796856 | 0.97 | TSHR (0.36) | TSHRHPGDACE2THRBPPARG | |
| SCHEMBL19796399 | 0.84 | SCN9A (0.38) | TSHRHPGDTHRBPPARGCNR1 | |
| SCHEMBL19796835 | 0.84 | SPHK1 (0.36) | TSHRHPGDTHRBPPARG | |
| SCHEMBL19796897 | 0.82 | THRB (0.38) | TSHRHPGDTHRBPPARG | |
| SCHEMBL19796855 | 0.82 | SCN9A (0.36) | TSHRHPGDTHRBPPARGCNR1 | |
| SCHEMBL19804011 | 0.82 | THRB (0.41) | TSHRHPGDTHRB | |
| SCHEMBL19796903 | 0.81 | HPGD (0.36) | TSHRHPGDTHRBPPARGCNR1 | |
| SCHEMBL19804649 | 0.80 | THRB (0.38) | TSHRTHRB | |
| SCHEMBL19796839 | 0.80 | SPHK1 (0.37) | TSHRHPGDTHRBPPARG | |
| SCHEMBL19796834 | 0.79 | THRB (0.36) | TSHRHPGDTHRBPPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180023001-A1 | COMPOUND HAVING POLYMERIZABLE GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC CORPORATION (JP) | 2018-01-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180023001-A1 | COMPOUND HAVING POLYMERIZABLE GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | SP1, C1S, AP3D1 | TSHR 4195/4885HPGD 4741/4885ACE2 3434/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.